Cargando…

Longitudinal assessment of quality assurance measurements in a 1.5 T MR‐linac: Part II—Magnetic resonance imaging

PURPOSE: To describe and report longitudinal quality assurance (QA) measurements for the magnetic resonance imaging (MRI) component of the Elekta Unity MR‐linac during the first year of clinical use in our institution. MATERIALS AND METHODS: The performance of the MRI component of Unity was evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Subashi, Ergys, Dresner, Alex, Tyagi, Neelam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398228/
https://www.ncbi.nlm.nih.gov/pubmed/35332990
http://dx.doi.org/10.1002/acm2.13586
_version_ 1784772288373063680
author Subashi, Ergys
Dresner, Alex
Tyagi, Neelam
author_facet Subashi, Ergys
Dresner, Alex
Tyagi, Neelam
author_sort Subashi, Ergys
collection PubMed
description PURPOSE: To describe and report longitudinal quality assurance (QA) measurements for the magnetic resonance imaging (MRI) component of the Elekta Unity MR‐linac during the first year of clinical use in our institution. MATERIALS AND METHODS: The performance of the MRI component of Unity was evaluated with daily, weekly, monthly, and annual QA testing. The measurements monitor image uniformity, signal‐to‐noise ratio (SNR), resolution/detectability, slice position/thickness, linearity, central frequency, and geometric accuracy. In anticipation of routine use of quantitative imaging (qMRI), we characterize B0/B1 uniformity and the bias/reproducibility of longitudinal/transverse relaxation times (T1/T2) and apparent diffusion coefficient (ADC). Tolerance levels for QA measurements of qMRI biomarkers are derived from weekly monitoring of T1, T2, and ADC. RESULTS: The 1‐year assessment of QA measurements shows that daily variations in each MR quality metric are well below the threshold for failure. Routine testing procedures can reproducibly identify machine issues. The longitudinal three‐dimensional (3D) geometric analysis reveals that the maximum distortion in a diameter of spherical volume (DSV) of 20, 30, 40, and 50 cm is 0.4, 0.6, 1.0, and 3.1 mm, respectively. The main source of distortion is gradient nonlinearity. Maximum peak‐to‐peak B0 inhomogeneity is 3.05 ppm, with gantry induced B0 inhomogeneities an order of magnitude smaller. The average deviation from the nominal B1 is within 2%, with minimal dependence on gantry angle. Mean ADC, T1, and T2 values are measured with high reproducibility. The median coefficient of variation for ADC, T1, and T2 is 1.3%, 1.1%, and 0.5%, respectively. The median bias for ADC, T1, and T2 is −0.8%, −0.1%, and 3.9%, respectively. CONCLUSION: The MRI component of Unity operates within the guidelines and recommendations for scanner performance and stability. Our findings support the recently published guidance in establishing clinically acceptable tolerance levels for image quality. Highly reproducible qMRI measurements are feasible in Unity.
format Online
Article
Text
id pubmed-9398228
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93982282022-08-24 Longitudinal assessment of quality assurance measurements in a 1.5 T MR‐linac: Part II—Magnetic resonance imaging Subashi, Ergys Dresner, Alex Tyagi, Neelam J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To describe and report longitudinal quality assurance (QA) measurements for the magnetic resonance imaging (MRI) component of the Elekta Unity MR‐linac during the first year of clinical use in our institution. MATERIALS AND METHODS: The performance of the MRI component of Unity was evaluated with daily, weekly, monthly, and annual QA testing. The measurements monitor image uniformity, signal‐to‐noise ratio (SNR), resolution/detectability, slice position/thickness, linearity, central frequency, and geometric accuracy. In anticipation of routine use of quantitative imaging (qMRI), we characterize B0/B1 uniformity and the bias/reproducibility of longitudinal/transverse relaxation times (T1/T2) and apparent diffusion coefficient (ADC). Tolerance levels for QA measurements of qMRI biomarkers are derived from weekly monitoring of T1, T2, and ADC. RESULTS: The 1‐year assessment of QA measurements shows that daily variations in each MR quality metric are well below the threshold for failure. Routine testing procedures can reproducibly identify machine issues. The longitudinal three‐dimensional (3D) geometric analysis reveals that the maximum distortion in a diameter of spherical volume (DSV) of 20, 30, 40, and 50 cm is 0.4, 0.6, 1.0, and 3.1 mm, respectively. The main source of distortion is gradient nonlinearity. Maximum peak‐to‐peak B0 inhomogeneity is 3.05 ppm, with gantry induced B0 inhomogeneities an order of magnitude smaller. The average deviation from the nominal B1 is within 2%, with minimal dependence on gantry angle. Mean ADC, T1, and T2 values are measured with high reproducibility. The median coefficient of variation for ADC, T1, and T2 is 1.3%, 1.1%, and 0.5%, respectively. The median bias for ADC, T1, and T2 is −0.8%, −0.1%, and 3.9%, respectively. CONCLUSION: The MRI component of Unity operates within the guidelines and recommendations for scanner performance and stability. Our findings support the recently published guidance in establishing clinically acceptable tolerance levels for image quality. Highly reproducible qMRI measurements are feasible in Unity. John Wiley and Sons Inc. 2022-03-25 /pmc/articles/PMC9398228/ /pubmed/35332990 http://dx.doi.org/10.1002/acm2.13586 Text en © 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Subashi, Ergys
Dresner, Alex
Tyagi, Neelam
Longitudinal assessment of quality assurance measurements in a 1.5 T MR‐linac: Part II—Magnetic resonance imaging
title Longitudinal assessment of quality assurance measurements in a 1.5 T MR‐linac: Part II—Magnetic resonance imaging
title_full Longitudinal assessment of quality assurance measurements in a 1.5 T MR‐linac: Part II—Magnetic resonance imaging
title_fullStr Longitudinal assessment of quality assurance measurements in a 1.5 T MR‐linac: Part II—Magnetic resonance imaging
title_full_unstemmed Longitudinal assessment of quality assurance measurements in a 1.5 T MR‐linac: Part II—Magnetic resonance imaging
title_short Longitudinal assessment of quality assurance measurements in a 1.5 T MR‐linac: Part II—Magnetic resonance imaging
title_sort longitudinal assessment of quality assurance measurements in a 1.5 t mr‐linac: part ii—magnetic resonance imaging
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398228/
https://www.ncbi.nlm.nih.gov/pubmed/35332990
http://dx.doi.org/10.1002/acm2.13586
work_keys_str_mv AT subashiergys longitudinalassessmentofqualityassurancemeasurementsina15tmrlinacpartiimagneticresonanceimaging
AT dresneralex longitudinalassessmentofqualityassurancemeasurementsina15tmrlinacpartiimagneticresonanceimaging
AT tyagineelam longitudinalassessmentofqualityassurancemeasurementsina15tmrlinacpartiimagneticresonanceimaging